This is a crime of occupational embezzlement stipulated in the criminal law. You have to report the case directly to the public security organ, but it is best to have certain evidence and the case will be filed. This is a huge amount
After reading your supplement, I will give you a case for reference. I hope it can help:
There has been new progress in the report of Jilin Pharmaceutical by many people. On Monday morning, Mr. Zhang Xianguo, a former supervisor of Jilin Pharmaceutical, went to the Jilin City Public Security Bureau with a report signed by hundreds of people to report Zhang Shoubin's suspected job embezzlement.
Zhang Shoubin was reported for suspected job embezzlement
The report materials stated: Jilin Henghe Weikang Pharmaceutical Co., Ltd. was originally a subsidiary of Jilin Pharmaceutical. On January 14, 2009, the reporter obtained the internal industrial and commercial files of Henghe Weikang at the Taonan City Industrial and Commercial Bureau in accordance with the law and found that Henghe Weikang was owned by Shi Lipeng. Among the relevant information on the equity transfer of Henghe Weikang is a resolution signed by the Jilin Pharmaceutical shareholders' meeting on July 27, 2007, which authorized Zhang Shoubin to sell Henghe Weikang. As a listed company, public information shows that Jilin Pharmaceutical did not hold a shareholders' meeting at all on July 27, 2007. This shareholders' meeting resolution was purely forged. On July 28, 2007, with forged authorization, Zhang Shoubin and Shi Lipeng privately signed an equity transfer agreement, transferring Henghe Weikang to Shi Lipeng for 14 million yuan; on August 27, 2007, Henghe Weikang completed the equity transfer, but the whereabouts of the transfer money of 14 million yuan is unknown. Zhang Shoubin's above-mentioned behavior constitutes the crime of job embezzlement.
Jilin Municipal Public Security Bureau refused to accept the report
Captain Xie of the Eighth Brigade of the Economic Investigation Detachment of Jilin Municipal Public Security Bureau received Zhang Xianguo and others. After reading the report materials, Captain Xie said he could not accept it.
"This company is a listed company. You should contact some departments that supervise listed companies, not us." Captain Xie did not accept the report material and asked the reporter to take it away by himself. Captain Xie also said: "Your evidence is insufficient. How can you prove that Zhang Shoubin kept the money in his own pocket?"
Lawyer Liu Lufeng from Hubei Dexin Law Firm believes that Jilin Pharmaceutical is listed as a listed company. A company must make an announcement when convening a general meeting of shareholders and passing resolutions. Unannounced resolutions of a general meeting of shareholders are invalid regardless of whether they are genuine or forged. As the legal representative of Jilin Pharmaceutical and the so-called agent entrusted by the resolution of the shareholders' meeting, Zhang Shoubin is also the seller's signatory and specific undertaker of the equity transfer agreement. He is obliged to transfer the proceeds from the sale of Henghe Weikang within the specified time in accordance with the agreement. into the account of Jilin Pharmaceutical. Now Henghe Weikang is still an asset of the listed company Jilin Pharmaceutical in the company's financial statements, while the industrial and commercial records belong to others. Legally, the ownership of the company is based on the industrial and commercial records. Therefore, Jilin Pharmaceutical This asset has been lost. From the perspective of crime composition, Zhang Shoubin has completed the crime of job embezzlement. In this case, neither the whistleblower nor the investigative agency needed to provide evidence to prove that the money was put into Zhang Shoubin's own pocket. Henghe Weikang was out of the company's control. Whether Zhang Shoubin got the money does not affect the composition of the crime.
In addition, as of press time, the China Securities Regulatory Commission has not responded to Lao Zhang’s report on Jilin Pharmaceutical on December 17.
Please consult a professional lawyer for specific details~ I can only try my best to help you, but after all, my experience is limited, so please bear with me~